Detalles de la búsqueda
1.
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
Breast Cancer Res Treat
; 117(1): 83-9, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19051009
2.
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Cancer Chemother Pharmacol
; 71(5): 1183-90, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23430121
3.
Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.
Clin Breast Cancer
; 12(2): 151-6, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22444722
4.
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.
J Clin Oncol
; 26(10): 1691-7, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18316792
Resultados
1 -
4
de 4
1
Próxima >
>>